Anandan, S.; Maciak, K.; Breinbauer, R.; Otero-Ortega, L.; Feliciello, G.; Stojanović Gužvić, N.; Torkildsen, O.; Myhr, K.-M.
In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis. Int. J. Mol. Sci. 2025, 26, 7213.
https://doi.org/10.3390/ijms26157213
AMA Style
Anandan S, Maciak K, Breinbauer R, Otero-Ortega L, Feliciello G, Stojanović Gužvić N, Torkildsen O, Myhr K-M.
In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis. International Journal of Molecular Sciences. 2025; 26(15):7213.
https://doi.org/10.3390/ijms26157213
Chicago/Turabian Style
Anandan, Shamundeeswari, Karina Maciak, Regina Breinbauer, Laura Otero-Ortega, Giancarlo Feliciello, Nataša Stojanović Gužvić, Oivind Torkildsen, and Kjell-Morten Myhr.
2025. "In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis" International Journal of Molecular Sciences 26, no. 15: 7213.
https://doi.org/10.3390/ijms26157213
APA Style
Anandan, S., Maciak, K., Breinbauer, R., Otero-Ortega, L., Feliciello, G., Stojanović Gužvić, N., Torkildsen, O., & Myhr, K.-M.
(2025). In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis. International Journal of Molecular Sciences, 26(15), 7213.
https://doi.org/10.3390/ijms26157213
